rs11146013
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_019892.6(INPP5E):c.1549+40G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., cov: 9)
Exomes 𝑓: 0.00011 ( 1 hom. )
Consequence
INPP5E
NM_019892.6 intron
NM_019892.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.323
Publications
0 publications found
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
INPP5E Gene-Disease associations (from GenCC):
- Joubert syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- MORM syndromeInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, ClinGen, Orphanet
- COACH syndrome 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndrome with ocular defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 9-136431784-C-T is Benign according to our data. Variant chr9-136431784-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 261198.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 14AN: 58998Hom.: 0 Cov.: 9 show subpopulations
GnomAD3 genomes
AF:
AC:
14
AN:
58998
Hom.:
Cov.:
9
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000637 AC: 10AN: 157032 AF XY: 0.0000462 show subpopulations
GnomAD2 exomes
AF:
AC:
10
AN:
157032
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000111 AC: 94AN: 849992Hom.: 1 Cov.: 15 AF XY: 0.000107 AC XY: 46AN XY: 431876 show subpopulations
GnomAD4 exome
AF:
AC:
94
AN:
849992
Hom.:
Cov.:
15
AF XY:
AC XY:
46
AN XY:
431876
show subpopulations
African (AFR)
AF:
AC:
9
AN:
20512
American (AMR)
AF:
AC:
2
AN:
28006
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
16894
East Asian (EAS)
AF:
AC:
1
AN:
21874
South Asian (SAS)
AF:
AC:
5
AN:
66966
European-Finnish (FIN)
AF:
AC:
0
AN:
25086
Middle Eastern (MID)
AF:
AC:
0
AN:
2900
European-Non Finnish (NFE)
AF:
AC:
76
AN:
632070
Other (OTH)
AF:
AC:
1
AN:
35684
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000237 AC: 14AN: 59020Hom.: 0 Cov.: 9 AF XY: 0.000179 AC XY: 5AN XY: 27940 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
14
AN:
59020
Hom.:
Cov.:
9
AF XY:
AC XY:
5
AN XY:
27940
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
5
AN:
13984
American (AMR)
AF:
AC:
0
AN:
5748
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1674
East Asian (EAS)
AF:
AC:
2
AN:
1986
South Asian (SAS)
AF:
AC:
0
AN:
1312
European-Finnish (FIN)
AF:
AC:
0
AN:
3598
Middle Eastern (MID)
AF:
AC:
0
AN:
134
European-Non Finnish (NFE)
AF:
AC:
6
AN:
29518
Other (OTH)
AF:
AC:
1
AN:
698
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.00000409021), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.336
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.